An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Tandem Diabetes Care, Inc. appoints Mark Novara as Executive Vice President and Chief Commercial Officer. Novara brings extensive global healthcare experience and will join the leadership team effective November 13, 2023.
Positive
None.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for nearly 25 years.
Mark Novara (Photo: Business Wire)
“Mark is a strategic, global leader with a successful track record of driving above market business growth, while building scalable commercial operations and delivering best-in-class customer experience,” said John Sheridan, president and CEO. “We welcome Mark to our leadership team at this exciting stage in Tandem’s evolution, as we prepare to expand our family of innovative technologies and execute on our shared vision to improve the lives of people with diabetes.”
“I was drawn to Tandem’s mission-driven commitment to innovation and their customer-centric culture,” said Mr. Novara. “Tandem has a strong portfolio powered by Control-IQ technology that provides compelling clinical results for people living with diabetes. I am excited to be joining Tandem at this pivotal time and look forward to working closely with the team to build on its strong foundation through new product launches, commercial excellence and global expansion.”
Mr. Novara joins Tandem Diabetes Care from McKinsey & Company, where he served as Senior Advisor in the Medical Technology/Life Science practice since February 2023. Before that time, Mr. Novara held executive positions at Becton Dickinson for more than a decade, most recently serving as Worldwide Vice President and General Manager in Medication Delivery Solutions, as Senior Vice President, Global Strategic Marketing for the Medical and Life Sciences Segments, and as Worldwide Vice President and General Manager in Diabetes Care. He also held leadership positions with Roche and Sanofi-Aventis. Mr. Novara received a BS in Biology from Villanova University, and a Masters in Healthcare Management from Columbia University.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 pump with Control-IQ technology. For more information, visit tandemdiabetes.com.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and #TandemDiabetes.
Follow Tandem Diabetes Care on Facebook at facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at linkedin.com/company/tandemdiabetes.
Who has Tandem Diabetes Care appointed as Executive Vice President and Chief Commercial Officer?
Tandem Diabetes Care has appointed Mark Novara as Executive Vice President and Chief Commercial Officer.
When will Mark Novara join the leadership team at Tandem Diabetes Care?
Mark Novara will join the leadership team at Tandem Diabetes Care on November 13, 2023.
What is Mark Novara's background and experience?
Mark Novara has nearly 25 years of experience in the diabetes, medical technology, and life sciences industries. He has held executive positions at Becton Dickinson, Roche, and Sanofi-Aventis, and served as a Senior Advisor at McKinsey & Company.
What is Tandem Diabetes Care's mission and vision?
Tandem Diabetes Care is committed to innovation and improving the lives of people with diabetes. They have a strong portfolio powered by Control-IQ technology.
What are Tandem Diabetes Care's plans for the future?
Tandem Diabetes Care plans to expand their family of innovative technologies, launch new products, achieve commercial excellence, and expand globally.
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
